CONCORD, N.H. (AP) — The New Hampshire Department of Health and Human Services has started accepting applications to provide medical marijuana to potentially qualifying patients and designated caregivers.
This is a pre-registration period for the Therapeutic Cannabis Program, giving people time to prepare before medical marijuana dispensaries are opened in the state.
The department says registry identification cards are not being issued at this time. They will be issued when the Alternative Treatment Center that a qualifying patient has selected obtains an authorization from the program to start dispensing medical marijuana.
It is anticipated that the four centers in New Hampshire will open in the first quarter of 2016.
Applicants who qualify will be sent a letter if they are approved.
“Applying for therapeutic cannabis registry cards is an important next step in the process for individuals who are in need and suffering from serious medical conditions and want to participate in the Therapeutic Cannabis Program,” Health Department Commissioner Nick Toumpas said.
“The pre-registration period is intended to give potentially qualifying patients and designated caregivers ample time to work with their providers to get registered before the dispensaries are open for business,” he said.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less